Cargando…

Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer

Disease outcomes of HER2+ breast cancers have dramatically improved after targeted therapies, such as trastuzumab became available. The main mechanism of action of trastuzumab depends on immunoactivation, while immunosuppressive tumour phenotype has been linked to adverse outcomes. Current study inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honkanen, Tiia J., Tikkanen, Antti, Karihtala, Peeter, Mäkinen, Markus, Väyrynen, Juha P., Koivunen, Jussi P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662906/ https://www.ncbi.nlm.nih.gov/pubmed/31358801 http://dx.doi.org/10.1038/s41598-019-47375-2

Ejemplares similares

Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
por: Honkanen, Tiia J., et al.
Publicado: (2021)

Prognostic and predictive role of spatially positioned tumour infiltrating lymphocytes in metastatic HER2 positive breast cancer treated with trastuzumab
por: Honkanen, Tiia J., et al.
Publicado: (2017)

Retrospective analysis of HER2 therapy interruption in patients responding to the treatment in metastatic HER2+ breast cancer
por: Moilanen, Tiina, et al.
Publicado: (2017)

Predictors of successful neoadjuvant treatment in HER2‑positive breast cancer
por: Hännikäinen, Elli-Noora, et al.
Publicado: (2023)

Role of human epidermal growth factor receptor 3 in treatment resistance of anaplastic lymphoma kinase translocated non-small cell lung cancer
por: Honkanen, Tiia J, et al.
Publicado: (2023)

Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers
por: Tikkanen, Antti, et al.
Publicado: (2020)

Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance
por: Tuomisto, Anne E, et al.
Publicado: (2019)

Clinical impact and network of determinants of tumour necrosis in colorectal cancer
por: Väyrynen, Sara A, et al.
Publicado: (2016)

Immunological and prognostic significance of tumour necrosis in colorectal cancer
por: Kastinen, Meeri, et al.
Publicado: (2023)

High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
por: Jääskeläinen, Anniina, et al.
Publicado: (2020)

A prognostic score based on B cell and plasma cell densities compared to T cell densities in colorectal cancer
por: Karjalainen, Henna, et al.
Publicado: (2023)

Prognostic factors in metastatic breast cancer: a prospective single-centre cohort study in a Finnish University Hospital
por: Karihtala, Peeter, et al.
Publicado: (2020)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer
por: Kuusisalo, Saara, et al.
Publicado: (2023)

Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
por: Hyytiäinen, Aini, et al.
Publicado: (2021)

The mutational signatures of cancer: can passengers set a direction for prognosis?
por: Karihtala, Peeter
Publicado: (2023)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer
por: Pylväs-Eerola, Marjo, et al.
Publicado: (2015)

Keap1 expression has independent prognostic value in pancreatic adenocarcinomas
por: Isohookana, Joel, et al.
Publicado: (2015)

The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy
por: Roininen, Nelli, et al.
Publicado: (2017)

Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
por: Karihtala, Peeter, et al.
Publicado: (2017)

Infracentimetric HER-2 positive breast tumours—review of the literature
por: da Fonseca Reis Silva, Danilo, et al.
Publicado: (2015)

Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival
por: Sirniö, Päivi, et al.
Publicado: (2018)

Real-world, single-centre prospective data of age at breast cancer onset: focus on survival and reproductive history
por: Karihtala, Peeter, et al.
Publicado: (2021)

Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer
por: Elomaa, Hanna, et al.
Publicado: (2022)

NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma
por: Immonen, Anni, et al.
Publicado: (2022)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

Mutational signatures and their association with survival and gene expression in urological carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2023)

The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer
por: Jääskeläinen, Minna M., et al.
Publicado: (2023)

Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival
por: Väyrynen, Juha P., et al.
Publicado: (2018)

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
por: Pizzuti, Laura, et al.
Publicado: (2021)

Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer
por: Sirniö, Päivi, et al.
Publicado: (2017)

Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer
por: Shikata, Shohei, et al.
Publicado: (2023)

Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
por: Teppo, Hanna-Riikka, et al.
Publicado: (2017)

A positive role for PEA3 in HER2-mediated breast tumour progression
por: Myers, E, et al.
Publicado: (2006)

Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
por: Kim, Ahrong, et al.
Publicado: (2017)

Metformin and ovarian cancer: the evidence
por: Urpilainen, Elina, et al.
Publicado: (2020)

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer
por: Viansone, A., et al.
Publicado: (2022)

Evaluation of in vitro and in vivo personalized cancer treatment assays for oral squamous cell carcinoma
por: Wahbi, Wafa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0l7ba3ans4fj5rrpdja01hfp84